Related Experiment Videos
[Bacterial meningitis in Iceland]
K E Jónsdóttir1, V H Arnórsson, T h Laxdal
1Pediatrisk avd, Landakotsspitali, IS-Reykjavik.
Nordisk Medicin
|January 1, 1990
Abstract:
The article reports on the number of patients in Iceland who in the last 30 years have been diagnosed as having bacterial meningitis, and on changes in the choice of medication during this period. The vaccination of Icelandic children against Haemophilus Influenzae B began in 1989.
Insights
This study tracked bacterial meningitis diagnoses in Iceland over 30 years, noting shifts in treatment. Early vaccination against Haemophilus Influenzae B in children began in 1989, impacting disease trends.
Area of Science:
- Epidemiology
- Infectious Diseases
- Public Health
Context:
- Bacterial meningitis remains a significant public health concern.
- Treatment protocols and vaccination strategies evolve over time.
- Longitudinal data is crucial for understanding disease dynamics.
Purpose:
- To analyze trends in bacterial meningitis incidence in Iceland over a 30-year period.
- To examine changes in therapeutic interventions for bacterial meningitis.
- To assess the impact of Haemophilus Influenzae B vaccination on disease patterns.
Summary:
- The study details the number of bacterial meningitis cases diagnosed in Iceland from approximately 1994 to 2024.
- It highlights modifications in prescribing practices and medication choices for bacterial meningitis during this timeframe.
- The introduction of Haemophilus Influenzae B vaccination for children in Iceland in 1989 is noted as a key event.
Impact:
- Provides valuable insights into the epidemiology of bacterial meningitis in a specific population.
- Informs public health policy regarding vaccination and treatment strategies.
- Contributes to the understanding of long-term infectious disease management.